Performance of dRAST on Prospective Clinical Blood Culture Samples in a Simulated Clinical Setting and on Multidrug-Resistant Bacteria

Performance of dRAST on Prospective Clinical Blood Culture Samples in a Simulated Clinical Setting and on Multidrug-Resistant Bacteria

ABSTRACT There is an utmost need for rapid antimicrobial susceptibility testing (AST) of bacteria causing bloodstream infections (BSI). The dRAST (QuantaMatrix Inc., Seoul) is a commercial method that can be performed directly from positive blood cultures. The present study aims to evaluate the perf...

Full description

Bibliographic Details
Main Authors: Alicia Y. W. Wong, Alexander T. A. Johnsson, Volkan Özenci
Format: Article
Language:English
Published: American Society for Microbiology 2022-04-01
Series:Microbiology Spectrum
Subjects:
automated antimicrobial susceptibility testing
bacteremia
blood culture
dRAST
Online Access:https://journals.asm.org/doi/10.1128/spectrum.02107-21

Internet

https://journals.asm.org/doi/10.1128/spectrum.02107-21

Similar Items